Full Year 2022 Hikma Pharmaceuticals PLC Earnings Presentation - Pre-Recorded Transcript

Feb 23, 2023 / 07:00AM GMT
Presentation - Pre-Recorded
Feb 23, 2023 / 07:00AM GMT

=====================
Corporate Participants
=====================
* Khalid Waleed Hosny Al Nabilsi
Hikma Pharmaceuticals PLC - CFO
* Said Samih Taleb Darwazah
Hikma Pharmaceuticals PLC - Executive Chairman & CEO

=====================
Said Samih Taleb Darwazah - Hikma Pharmaceuticals PLC - Executive Chairman & CEO

Hello, everyone. I'm Said Darwazah, CEO and Executive Chairman of Hikma, and I'm here with Khalid Nabilsi, our CFO. Thank you for joining our 2022 full year results presentation.

I will kick off by providing a quick summary of our results and an update on our strategic progress. Then I will hand over to Khalid to take you through the financials.

I am pleased to report that the group delivered a resilient set of results in 2022. This was achieved despite a challenging backdrop, demonstrating the strength of our diversified business model. During the year, we were impacted by severe competitive pressure in our Generics business, higher costs due to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot